BioPorto A/S to Host Second Quarter 2023 Earnings Webcast and Analyst Call
July 7, 2023News Release BioPorto A/S to Host Second Quarter 2023 Earnings Webcast and Analyst Call COPENHAGEN, Denmark and BOSTON,...
Month: July 2023
Abeona Therapeutics Announces Closing of $25 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
CLEVELAND, July 07, 2023 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) announced the closing of its previously announced registered...
SmileDirectClub to Report Second Quarter 2023 Results on August 8, 2023
NASHVILLE, Tenn., July 07, 2023 (GLOBE NEWSWIRE) -- SmileDirectClub, Inc. (Nasdaq: SDC), the next generation oral care company with the...
Xtant Medical Announces Closing of $15 Million Private Placement
BELGRADE, Mont., July 07, 2023 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company...
European Patent Granted for ZyVersa Therapeutics’ Lead Asset, Cholesterol Efflux Mediator™ VAR 200 for Use in Patients with Diabetic Nephropathy/Diabetic Kidney Disease
Cholesterol Efflux Mediator™ VAR 200 is in phase 2a development to reduce renal cholesterol and lipid accumulation that damages the kidneys'...
AMN Healthcare to Hold Second Quarter 2023 Earnings Conference Call on Thursday, August 3, 2023
DALLAS, July 07, 2023 (GLOBE NEWSWIRE) -- AMN Healthcare Services, Inc. (NYSE: AMN), has scheduled a conference call to discuss...
Orion Corporation: Change in Orion Group Executive Management Board as of 30 April 2024
ORION CORPORATION STOCK EXCHANGE RELEASE – CHANGES BOARD / MANAGEMENT / AUDITORS7 July 2023 at 14.30 EEST Orion Corporation: Change in...
Advanced FDA Cleared Magstim Horizon 3.0 Transcranial Magnetic Stimulation Now Available in United Kingdom
Approval by UKCA Empowers UK Physicians to Advance Care of Treatment Resistant Depression, Obsessive Compulsive Disorder, and Anxious Depression with...
Axsome Therapeutics Initiates FOCUS Phase 3 Trial of Solriamfetol for the Treatment of Attention Deficit Hyperactivity Disorder (ADHD) in Adults
NEW YORK, July 07, 2023 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel...
Late-Breaking KidneyIntelX Evidence Released at 83rd American Diabetes Association Scientific Sessions
12 Months KidneyIntelX™ in vitro prognostic testing continued to demonstrate clinical actions that lead to improvement in both diabetes (A1C...
InvestmentPitch Media Video Discusses Reliq Health’s Expansion into Mexico, Anticipates Adding more than 10,000 New Patients to Platform
VANCOUVER, British Columbia, July 07, 2023 (GLOBE NEWSWIRE) -- Reliq Health Technologies Inc. (TSXV:RHT) (OTCPink:RQHTF) (FSE:MHN2), a rapidly growing global...
Coloplast A/S – Announcement no. 03/2023 – Coloplast announces agreement to acquire Kerecis and raises long-term growth expectations
Coloplast has signed an agreement to acquire Kerecis, an innovative, fast-growing company in the biologics wound care segment, for up...
FDA Grants Traditional Approval for LEQEMBI® (lecanemab-irmb) for the Treatment of Alzheimer’s Disease
The first and only approved treatment shown to reduce the rate of disease progression and to slow cognitive and functional...
Breakthrough in Alzheimer’s Disease Treatment: Alzheimer Society of Ontario Applauds US Approval of Game-Changing Disease-Modifying Therapy
First-ever full approval paves the way for widespread access to lecanemab for US residents—Sparking hope for CanadiansTORONTO, July 06, 2023...
BioSyent Pharma to Introduce Gelclair® at AHNS 11th International Conference on Head and Neck Cancer
MISSISSAUGA, Ontario, July 06, 2023 (GLOBE NEWSWIRE) -- BioSyent Pharma Inc. (“BioSyent Pharma”), a subsidiary of BioSyent Inc. (“BioSyent”, “the...
Cronos Group Inc. confirms receipt of unsolicited indications of interest
TORONTO, July 06, 2023 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) today confirmed that...
Blue Water Biotech Secures License from Ohio State Board of Pharmacy to Operate as Pharmaceutical Wholesaler for its FDA Approved Products
First state license is a key achievement as Blue Water continues to expand its business into commercial activitiesCINCINNATI, July 06, 2023...
New Report from Inovalon and Harvard Reveals Notable Differences Between Those Opting for Medicare Advantage vs. Traditional Medicare
Collaborative Research Provides Actionable Insights for Payers and Policymakers on Optimizing Plans to Best Meet the Needs of the Rapidly...
Carrick Therapeutics Announces Clinical Trial Collaboration with Arvinas and Pfizer to Evaluate Samuraciclib and Vepdegestrant Combination
Collaboration expands Carrick’s clinical-stage Oncology programDUBLIN, Ireland and BOSTON, July 06, 2023 (GLOBE NEWSWIRE) -- Carrick Therapeutics, an oncology-focused biopharmaceutical...
The International Myeloma Foundation’s Nurse Leadership Board Launches Myeloma University
A Comprehensive Online Educational Program on Multiple MyelomaLOS ANGELES, July 06, 2023 (GLOBE NEWSWIRE) -- The International Myeloma Foundation’s (IMF)...